National Engineering Laboratory for Modern Silk, College of Textile and Clothing Engineering, Soochow University, Suzhou 215123, China.
Laboratory Animal Center of Soochow University, Suzhou, China 215123.
Mater Sci Eng C Mater Biol Appl. 2019 Sep;102:820-828. doi: 10.1016/j.msec.2019.05.004. Epub 2019 May 3.
Poly(d,l-lactide-co-glycolide) (PLGA) microspheres have been used as an injectable depot for prolonged release of octreotide (Sandostatin LAR®), a peptide drug for the treatment of acromegaly and gastrointestinal tumors. However, acylation and incomplete release of the encapsulated octreotide, as well as acidic degradation product-induced inflammation are the major challenges hampering widespread clinical applications of this delivery system. The purpose of this study was to develop a novel octreotide-delivering system utilizing naturally derived biodegradable material, silk fibroin (SF). Octreotide acetate was encapsulated in the SF microspheres with a high loading (8-10 wt%) using polyethylene glycol (PEG)-assisted emulsification method. The octreotide-SF microspheres exhibited a silk I structure (low crystallinity) and burst release in in vitro release studies. Ethanol treatment after microsphere formation significantly increased β-sheet and silk II structure (high crystallinity) of the microspheres, significantly reducing the burst release and resulting in zero-order sustained release of octreotide over 102 days, and the data could be fit to the diffusion-driven release model. After the ethanol-treated microspheres were intramuscularly injected into rats at low (2 mg/kg) and high (8 mg/kg) octreotide doses, the plasma concentration of octreotide in the high dose group remained high (>50 pg/mL) at day 28 when compared to that of the control (pure drug at low dose) and low dose microsphere group. Interestingly, the plasma concentration for the high dose group at day 56 dramatically increased to >280 pg/mL observed at day 28. The low dose microsphere group showed a similar increase, but at a much lower level. The rebound octreotide level likely reflected degradation of the SF matrix which released tightly bound/trapped octreotide. Therefore, SF microspheres can deliver octreotide over a long period of time with release kinetics and the mechanism different from PLGA microsphere system.
聚(D,L-丙交酯-共-乙交酯)(PLGA)微球已被用作奥曲肽(善得定 LAR®)的可注射储库,奥曲肽是一种用于治疗肢端肥大症和胃肠道肿瘤的肽类药物。然而,包封的奥曲肽的酰化和不完全释放,以及酸性降解产物诱导的炎症,是阻碍这种给药系统广泛临床应用的主要挑战。本研究的目的是开发一种利用天然可生物降解材料丝素蛋白(SF)的新型奥曲肽递送系统。采用聚乙二醇(PEG)辅助乳化法,将醋酸奥曲肽包封在 SF 微球中,载药量高(8-10wt%)。奥曲肽-SF 微球在体外释放研究中表现出丝 I 结构(低结晶度)和突释。微球形成后进行乙醇处理,显著增加了微球的β-折叠和丝 II 结构(高结晶度),显著降低了突释,使奥曲肽在 102 天内呈零级持续释放,数据可拟合扩散驱动释放模型。将乙醇处理后的微球以低(2mg/kg)和高(8mg/kg)奥曲肽剂量肌肉注射入大鼠体内后,与对照组(低剂量纯药物)和低剂量微球组相比,高剂量组在第 28 天的奥曲肽血浆浓度仍保持在较高水平(>50pg/mL)。有趣的是,高剂量组在第 56 天的血浆浓度急剧增加到第 28 天观察到的>280pg/mL。低剂量微球组也出现了类似的增加,但水平要低得多。奥曲肽的反弹水平可能反映了 SF 基质的降解,释放了紧密结合/捕获的奥曲肽。因此,SF 微球可以在很长一段时间内以不同于 PLGA 微球系统的释放动力学和机制来输送奥曲肽。